Simon Tate's most recent trade in Climb Bio Inc. was a trade of 10,000 Stock Option (Right To Buy) done . Disclosure was reported to the exchange on June 26, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Climb Bio Inc. | Simon Tate | Director | 26 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (Right To Buy) | ||
Climb Bio Inc. | Simon Tate | Director | 18 May 2023 | 10,000 | 10,000 | - | - | Stock Option (Right To Buy) | ||
Climb Bio Inc. | Simon Tate | Director | 19 May 2022 | 10,000 | 10,000 | - | - | Stock Option (Right To Buy) | ||
Climb Bio Inc. | Simon Tate | Director | 09 Aug 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |